ID   BM1R2
AC   CVCL_E9WB
RX   PubMed=10628353;
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=10628353).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1339 ! KP-N-RT-BM-1
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=10628353;
RA   Yasuno, Tetsuya
RA   Matsumura, Takafumi
RA   Shikata, Takuma
RA   Inazawa, Johji
RA   Sakabe, Tomoya
RA   Tsuchida, Shigeki
RA   Takahata, Takenori
RA   Miyairi, Shinichi
RA   Naganuma, Akira
RA   Sawada, Tadashi
RT   "Establishment and characterization of a cisplatin-resistant human
RT   neuroblastoma cell line.";
RL   Anticancer Res. 19:4049-4057(1999).
//